>
Novan Inc logo

NOVN - Novan Inc Share Price

$1.16 -0.0  -1.3%

Last Trade - 11/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £123.9m
Enterprise Value £99.2m
Revenue £3.48m
Position in Universe 4622nd / 6853
Bullish
Bearish
Unlock NOVN Revenue
Momentum
Relative Strength (%)
1m -23.1%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -55.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 2.14 5.99 4.90 4.92 3.74 3.26
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, NovanInc revenues remained flat at $4.9M. Net loss decreased 4%to $29.3M. Revenues reflect Revenue Sales of Goods &Services increase of 70% to $712K, also reflect License andcollaboration revenue decrease of 6% to $4.2M. Lower netloss reflects Research and Development - Balancing decreaseof 22% to $19M (expense), Other (expense) income increasefrom $136K to $870K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

NOVN Revenue Unlock NOVN Revenue

Net Income

NOVN Net Income Unlock NOVN Revenue

Normalised EPS

NOVN Normalised EPS Unlock NOVN Revenue

PE Ratio Range

NOVN PE Ratio Range Unlock NOVN Revenue

Dividend Yield Range

NOVN Dividend Yield Range Unlock NOVN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
NOVN EPS Forecasts Unlock NOVN Revenue
Profile Summary

Novan, Inc. is a clinical development-stage biotechnology company. The Company is focused on leveraging nitric oxide’s naturally occurring anti-microbial and immunomodulatory mechanisms of action to treat a range of diseases. The Company has created a Nitricil technology platform enabling the development of new chemical entities (NCEs) with delivery of nitric oxide. The Company’s two key components of its nitric oxide platform are its Nitricil technology, which drives the creation of NCEs, and its formulation science, both of which it uses to tune its product candidates for specific indications. Novan’s Nitricil technology enables it to store large amounts of nitric oxide gas in a stable, solid form by chemically loading it on a macromolecule, or polymer. The nitric oxide platform has produced a portfolio that includes the various clinical stage dermatology product candidates: SB204, SB206, SB208 and SB414.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated January 27, 2006
Public Since September 21, 2016
No. of Shareholders: 126
No. of Employees: 23
Sector Healthcare
Industry Pharmaceuticals
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 151,653,150
Free Float (0.0%)
Eligible for
ISAs
SIPPs
NOVN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for NOVN
Upcoming Events for NOVN
Frequently Asked Questions for Novan Inc
What is the Novan Inc share price?

As of 11/05/21, shares in Novan Inc are trading at $1.16, giving the company a market capitalisation of £123.9m. This share price information is delayed by 15 minutes.

How has the Novan Inc share price performed this year?

Shares in Novan Inc are currently trading at $1.16 and the price has moved by 0.194k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Novan Inc price has moved by 0.102k% over the past year.

What are the analyst and broker recommendations for Novan Inc?

Of the analysts with advisory recommendations for Novan Inc, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Novan Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Novan Inc next release its financial results?

Novan Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Novan Inc dividend yield?

Novan Inc does not currently pay a dividend.

Does Novan Inc pay a dividend?

Novan Inc does not currently pay a dividend.

When does Novan Inc next pay dividends?

Novan Inc does not currently pay a dividend.

How do I buy Novan Inc shares?

To buy shares in Novan Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Novan Inc?

Shares in Novan Inc are currently trading at $1.16, giving the company a market capitalisation of £123.9m.

Where are Novan Inc shares listed? Where are Novan Inc shares listed?

Here are the trading details for Novan Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: NOVN
What kind of share is Novan Inc?

Based on an overall assessment of its quality, value and momentum, Novan Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Novan Inc share price forecast 2021?

Shares in Novan Inc are currently priced at $1.16. At that level they are trading at 0.16% discount to the analyst consensus target price of 0.00.

Analysts covering Novan Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.19 for the next financial year.

How can I tell whether the Novan Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Novan Inc. Over the past six months, the relative strength of its shares against the market has been 0.101k%. At the current price of $1.16, shares in Novan Inc are trading at 22.36% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Novan Inc PE Ratio?

We were not able to find PE ratio data for Novan Inc.

Who are the key directors of Novan Inc?

Novan Inc's management team is headed by:

Robert Ingram - IND
W. Geer - LED
Robert Keegan - IND
John Palmour - IND
Paula Stafford - CHM
John Gay - CFO
James Bierman - DRC
Who are the major shareholders of Novan Inc?

Here are the top five shareholders of Novan Inc based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 4.59% (6.96m shares)
Reedy Creek Investments, LLC. Corporation
Percentage owned: 2.6% (3.95m shares)
Vanguard Total Stock Market Index Fund Mutual Fund
Percentage owned: 2.54% (3.85m shares)
Moglia (Joseph H) Individual Investor
Percentage owned: 2.1% (3.18m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 1.76% (2.66m shares)
Similar to NOVN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.